Complications associated with blood loss and transfusion following total knee arthroplasty

Seminars in Arthroplasty JSES

Volumn 13, Issue 1, 2002, Pages 64-68

  Cushner, Fred D ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMODILUTION; HUMAN; INFECTION RISK; INTRAOPERATIVE PERIOD; POSTOPERATIVE PERIOD; SURGICAL TECHNIQUE; TOTAL KNEE REPLACEMENT;

EID: 0036268696     PISSN: 10454527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Patient specific transfusion options in total hip and knee surgery
2. Infection or suspected infection after total hip replacement surgery with autologous or homologous blood transfusion
3. Erythrocyte transfusion causes immunosuppression after total hip replacement
4. An analysis of blood management in patients having a total hip or knee arthroplasty
5. Predonated autologous blood transfusion after total knee arthroplasty
6. Assessment of post-operative vigor in patients undergoing elective total joint arthroplasty: A concise patient and caregiver instrument
7. Blood loss in TKA
8. Blood loss with total knee arthroplasty
9. Alternatives to allogeneic blood use in surgery: Acute normovolemic hemodilution and preoperative autologous donation
10. Evolution of blood transfusion management for a busy knee practice
11. Blood management experience: Relationship between autologous blood donation and transfusion in orthopaedic surgery
12. In search of the transfusion trigger
13. An open-label randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous donation in total joint arthroplasty
14. The cost effectiveness of preoperative autologous donations
15. Preoperative autologous donation for total joint arthroplasty
16. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement
17. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having major orthopaedic operations: The erythropoietin study group
18. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients
19. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery
20. Reinfusion of shed blood after orthopaedic procedures in children and adolescents
21. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery
22. Postoperative blood salvage and reinfusion after total joint arthroplasty
23. Haematological effects of postoperative autotransfusion in spinal surgery
24. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty
25. Reinfusion of postoperative wound drainage in joint arthroplasty
26. Unwashed filtered shed blood collected after knee and hip arthroplasties
27. Salvage and reinfusion of postoperative sanguineous wound drainage
28. Autologous blood transfusion: Results with routine use of autologous blood transfusion, normovolemic hemodilution and postoperative retransfusion of drainage blood salvaged with the sulcotrans system
29. Efficacy of blood salvage devices following TKA in patients with and without deposited autologous units